Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 18, 2024

BUY
$0.0 - $23.99 $0 - $9,236
385 New
385 $9,000
Q1 2023

Apr 17, 2023

BUY
$12.98 - $17.1 $1,025 - $1,350
79 Added 790.0%
89 $1,000
Q4 2022

Jan 17, 2023

BUY
$13.92 - $17.0 $13 - $17
1 Added 11.11%
10 $0
Q3 2022

Oct 21, 2022

BUY
$13.36 - $16.75 $120 - $150
9 New
9 $0

Others Institutions Holding ABCM

About Abcam plc


  • Ticker ABCM
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 229,044,992
  • Description
  • Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...
More about ABCM
Track This Portfolio

Track Ronald Blue Trust, Inc. Portfolio

Follow Ronald Blue Trust, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ronald Blue Trust, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ronald Blue Trust, Inc. with notifications on news.